Collaborative Projects
Collaborative Projects, funded by the ӳý-ISF Partnership, unite scientists from different areas of expertise at the ӳý and at Israeli institutions to pursue multi-year, multi-investigator, and multi-institute efforts to promote interdisciplinary collaborations and engage in transformative, novel and groundbreaking projects that may often be high risk but with significant potential for impact.
With this new focus, we aim to increase the impact, power, and scale of high-quality projects that require longer timelines. We also seek to recruit leaders and experts who have the ability to solve complex problems in biomedicine — especially those problems served by the unique talents of Israeli scientists and the unique resources (e.g., EMRs, diverse ethnic backgrounds) in Israel. Additionally, we hope to engage with a broader pool of Israeli talent.
Awardees, 2018 – 2019
2019
- (Weizmann Institute of Science) and Samouil Farhi (ӳý): “Accelerating tissue structure mapping through compressed sensing”
- (Weizmann Institute of Science) and (Massachusetts General Hospital and ӳý): “Integrating cellular state and plasticity into glioblastoma therapeutics”
- Gali Pariente (Ben-Gurion University), (Hebrew University), and Ramnik Xavier (ӳý): “The specialization of the infant gut microbiome — a trans continents comparison”
- (Technion) and (Harvard Medical School and ӳý): “Antibiotic resistance mutations within their epistatic landscape”
2018
- (Bar-Ilan University), (Weizmann Institute of Science), (Harvard Medical School and ӳý), and (Harvard Medical School and ӳý): “Exploring spatial and temporal dynamics of the neuro-immune-microbiome interactions triangle in inflammatory bowel diseases”
- (Chaim Sheba Medical Center and Tel Aviv University), Jonathan Livny (ӳý), and Ashlee Earl (ӳý): “Salmonella adaptations and host responses leading to long-term persistence in humans”
- (Hebrew University), (Hebrew University), and , (ӳý): “Dynamics and combinatorics of chromatin remodelers in health and disease”
- (Hebrew University), (Hebrew University), and (Massachusetts General Hospital and ӳý): “Heterogeneity in the tumor and its microenvironment as a driving force in pancreatic cancer — the roles of senescent cells”
-
(Tel Aviv University), (Tel Aviv University), (Israel Antiquities Authority), and (Harvard Medical School and ӳý): “Ancient DNA as a lens for understanding the ancient people of the Levant”
Information about projects funded during the first phase of the ӳý-ISF partnership (2012-2017) is available here.
